Integrin alpha 10, CD44, PTEN, cadherin-11 and lactoferrin expressions are potential biomarkers for selecting patients in need of central nervous system prophylaxis in diffuse large B-cell lymphoma-Reference-Cited by-同舟云学术

Integrin alpha 10, CD44, PTEN, cadherin-11 and lactoferrin expressions are potential biomarkers for selecting patients in need of central nervous system prophylaxis in diffuse large B-cell lymphoma

Published:2017-07-17 Issue:8 Volume:38 Page:812-820
ISSN:0143-3334
Container-title:Carcinogenesis
language:en
Short-container-title:

Author:

Lemma Siria A¹²,Kuusisto Milla¹²,Haapasaari Kirsi-Maria¹²³,Sormunen Raija³⁴,Lehtinen Tuula⁵,Klaavuniemi Tuula⁵⁶,Eray Mine⁷,Jantunen Esa⁸,Soini Ylermi⁹¹⁰,Vasala Kaija⁶,Böhm Jan¹¹,Salokorpi Niina¹²,Koivunen Petri¹³,Karihtala Peeter¹²,Vuoristo Jussi³⁴,Turpeenniemi-Hujanen Taina¹²,Kuittinen Outi¹²

Affiliation:

1. Department of Oncology and Radiotherapy, Medical Research Center Oulu, Oulu University Hospital, University of Oulu, Kajaanintie 50, 90220 Oulu, Finland,

2. Cancer and Translational Medicine Research Unit, Faculty of Medicine, University of Oulu, Kajaanintie 50, 90220 Oulu, Finland,

3. Department of Pathology, Institute of Diagnostics, Medical Research Center Oulu, Oulu University Hospital, Kajaanintie 50, 90220 Oulu, Finland,

4. Biocenter Oulu, University of Oulu, Kajaanintie 50, 90220 Oulu, Finland,

5. Department of Oncology, Tampere University Hospital, Teiskontie 35, 33521 Tampere, Finland,

6. Department of Oncology and Radiotherapy, Central Finland Central Hospital, Keskussairaalantie 19, 40620 Jyväskylä, Finland,

7. Department of Pathology, FIMLAB, Tampere University Hospital, Teiskontie 35, 33521 Tampere, Finland,

8. Department of Medicine, Kuopio University Hospital, Puijonlaaksontie 2, 70210 Kuopio, Finland,

9. Department of Clinical Pathology and Forensic Medicine, Cancer Center of Eastern Finland, University of Eastern Finland, Puijonlaaksontie 2, 70210 Kuopio, Finland,

10. Kuopio University Hospital, Puijonlaaksontie 2, 70210 Kuopio, Finland,

11. Department of Pathology, Central Finland Central Hospital, Keskussairaalantie 19, 40620 Jyväskylä, Finland,

12. Department of Neurosurgery, Medical Research Center Oulu, Oulu University Hospital, University of Oulu, Kajaanintie 50, 90220 Oulu, Finland and

13. Department of Otorhinolaryngology, Medical Research Center Oulu, Oulu University Hospital, University of Oulu, Kajaanintie 50, 90220 Oulu, Finland

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,General Medicine

Link

http://academic.oup.com/carcin/article-pdf/38/8/812/24346786/bgx061.pdf

Reference49 articles.

1. Primary CNS lymphoma;Hochberg;Nat. Clin. Pract. Neurol,(2007)

2. For which patients with aggressive non-Hodgkin’s lymphoma is prophylaxis for central nervous system disease mandatory? Dutch HOVON Group;Bos;Ann. Oncol,(1998)

3. Risk factors, treatment, and outcome of central nervous system recurrence in adults with intermediate-grade and immunoblastic lymphoma;van Besien;Blood,(1998)

4. Central nervous system (CNS) relapse in diffuse large B cell lymphoma (DLBCL): pre- and post-rituximab;Tai;Ann. Hematol,(2011)

5. Central nervous system involvement in diffuse large B-cell lymphoma;Yamamoto;Eur. J. Haematol,(2010)

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting the tumor microenvironment in primary central nervous system lymphoma: Implications for prognosis;Journal of Clinical Neuroscience;2024-06

2. ITGA10 can be used as a potential diagnostic and prognostic biomarker of thyroid cancer;Asian Journal of Surgery;2024-06

3. Recent updates on central nervous system prophylaxis in patients with high-risk diffuse large B-cell lymphoma;Experimental Hematology & Oncology;2024-01-03

4. Testicular diffuse large B-cell lymphoma. Clinical lecture and case report;Acta Biomedica Scientifica;2023-12-06

5. Integrins and the Metastasis-like Dissemination of Acute Lymphoblastic Leukemia to the Central Nervous System;Cancers;2023-04-27